Category: Company
Industry: Drug Manufacturers - Major Quick infos Headquarters: United States of America Trade prices Volume: Market Cap: 708.01M Prev closed: 39.65 Open: 39.9 High: 40.41 Low: 38.96 52 week low: 38.96 52 week high: 125 Dividends: No Dividends Next ER: May 6, 2021 Before Market Opens
About the Company Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.
Earnings History Date EPS / Forecast Revenue / Forecast May 6, 2021 - / -1.56- / 84.25MFebruary 25, 2021 -1.58 / -1.4883.27M / 85.03MNovember 9, 2020 -2.01 / -1.9979.52M / 78.67MBeat! August 10, 2020 -1.92 / -2.8877.25M / 72.45MBeat! July 30, 2020 - / -2.94- / 72.01Mview more
Historical Data Date Price Open High Low Vol Change ER Jun 14, 2021 22.32 21.70 22.32
21.70
80.94K 3.53% Jun 11, 2021 21.56 21.51 21.90
20.91
556.02K 0.28% Jun 10, 2021 21.50 21.35 21.93
20.88
878.13K 0.47% Jun 9, 2021 21.40 20.27 21.62
20.16
1.21M 7.86% Jun 8, 2021 19.84 19.48 19.89
18.78
675.30K 3.33% Jun 7, 2021 19.20 18.20 19.34
17.70
1.19M 6.61% Jun 4, 2021 18.01 17.90 18.18
17.60
533.98K 0.50% Jun 3, 2021 17.92 17.57 18.22
17.22
700.86K 2.22% Jun 2, 2021 17.53 17.41 17.88
17.22
874.30K 2.16% Jun 1, 2021 17.16 16.60 17.30
16.52
760.47K 3.19% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2002 Employees:456 News
Intercept Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com May 25, 2021 6:45 am
Intercept to Present at the 2021 RBC Capital Markets Global Healthcare Conference finance.yahoo.com May 12, 2021 8:00 am
Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Beat finance.yahoo.com May 7, 2021 12:23 pm
Intercept Pharmaceuticals (ICPT) Reports Q1 Loss, Tops Revenue Estimates finance.yahoo.com May 6, 2021 8:35 am
Intercept Pharmaceuticals (ICPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release finance.yahoo.com Apr 29, 2021 5:06 pm
With Important Trial Results Due in June, Is This Drugmaker a Good Buy Now? fool.com Apr 23, 2021 10:02 am
3 Stocks Primed for a Short Squeeze fool.com Apr 4, 2021 6:06 am
Strong Insider Buying Could Indicate a Bottom in These 2 Stocks finance.yahoo.com Mar 24, 2021 9:47 pm
Intercept Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Mar 12, 2021 6:30 am
Intercept Announces Departure of Chief Financial Officer finance.yahoo.com Mar 10, 2021 8:00 am Intercept Pharmaceuticals Inc (ICPT) Q4 2020 Earnings Call Transcript fool.com Feb 25, 2021 12:00 pm
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intercept Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm finance.yahoo.com Feb 23, 2021 9:00 pm
Rosen, A Longstanding and Trusted Firm, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action - ICPT finance.yahoo.com Feb 23, 2021 8:15 pm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Raytheon, Intercept Pharmaceuticals, Neovasc, and Interface and Encourages Investors to Contact the Firm finance.yahoo.com Feb 23, 2021 6:00 pm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Intercept Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2021 - ICPT finance.yahoo.com Feb 23, 2021 4:28 pm
ICPT LOSS ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Encourages Intercept Pharmaceuticals, Inc. Investors to Seek Counsel Before Important Deadline in Securities Class Action ICPT finance.yahoo.com Feb 23, 2021 4:15 pm
Rosen, Top Ranked Investor Counsel, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPT finance.yahoo.com Feb 23, 2021 4:03 pm
ICPT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 4, 2021 in the Class Action Filed on Behalf of Intercept Pharmaceuticals, Inc. Limited Shareholders finance.yahoo.com Feb 23, 2021 3:22 pm
SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Feb 23, 2021 2:45 pm
FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Feb 23, 2021 1:55 pm This company doesn't provide a dividend.
Key Persons CEO : Mark E. Pruzanski, MD Chief Human Resources Officer : David Ford Talk about Intercept Pharma below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
